Carcinomas comprise about 90% of all human tumors and arise through the genetic alteration of epithelial cells. Many human carcinomas, including those of the breast, consist of neoplastic epithelial cells intermingled with a complex mixture of cells, including fibroblasts, myofibroblasts, endothelial cells and immune cells, which collectively form the tumor stroma. The supporting stroma of a carcinoma is distinct from that found in the adjacent normal tissue, and as the carcinoma expands, these stromal cells are recruited and induced to proliferate. The presence of stromal cell types within carcinomas is a powerful determinant of the biology of a tumor through its ability to have profound influences on the growth, survival, invasiveness, and metastatic powers of the neoplastic epithelial cells. The presence of these cells has been demonstrated by our laboratory and others to have an essential role in supporting tumor progression; however, the mechanisms of stromal recruitment and how these cells contribute to tumor growth are not well understood. The proposed studies are directed at elucidating the recruitment of stromal cells and the mechanisms by which they influence tumor progression by accomplishing the following: A1. Determining the origins of the tumor-associated stromal cells; A2. Determining the nature of the signals used to recruit stromal precursor cells; A3. Characterizing the heterotypic signals released by recruited stromal cells that influence invasion and metastasis by carcinoma cells; A4. Determining the mechanisms by which mesenchymal stem cells can enhance metastatic ability.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA126515-05
Application #
8104119
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
5
Fiscal Year
2010
Total Cost
$381,340
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Naba, Alexandra; Pearce, Oliver M T; Del Rosario, Amanda et al. (2017) Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. J Proteome Res 16:3083-3091
Ragelle, Héloïse; Naba, Alexandra; Larson, Benjamin L et al. (2017) Comprehensive proteomic characterization of stem cell-derived extracellular matrices. Biomaterials 128:147-159
Gocheva, Vasilena; Naba, Alexandra; Bhutkar, Arjun et al. (2017) Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. Proc Natl Acad Sci U S A 114:E5625-E5634
Engblom, Camilla; Pfirschke, Christina; Zilionis, Rapolas et al. (2017) Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science 358:
Naba, Alexandra; Clauser, Karl R; Mani, D R et al. (2017) Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression. Sci Rep 7:40495
Pucci, Ferdinando; Garris, Christopher; Lai, Charles P et al. (2016) SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions. Science 352:242-6
Pfirschke, Christina; Engblom, Camilla; Rickelt, Steffen et al. (2016) Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity 44:343-54
Naba, Alexandra; Clauser, Karl R; Ding, Huiming et al. (2016) The extracellular matrix: Tools and insights for the ""omics"" era. Matrix Biol 49:10-24
Pucci, Ferdinando; Rickelt, Steffen; Newton, Andita P et al. (2016) PF4 Promotes Platelet Production and Lung Cancer Growth. Cell Rep 17:1764-1772
Naba, Alexandra; Clauser, Karl R; Hynes, Richard O (2015) Enrichment of Extracellular Matrix Proteins from Tissues and Digestion into Peptides for Mass Spectrometry Analysis. J Vis Exp :e53057

Showing the most recent 10 out of 59 publications